Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Envoy Medical (COCH) Gross Profit (2022 - 2025)

Envoy Medical's Gross Profit history spans 4 years, with the latest figure at -$363000.0 for Q3 2025.

  • For Q3 2025, Gross Profit fell 177.1% year-over-year to -$363000.0; the TTM value through Sep 2025 reached -$962000.0, up 32.16%, while the annual FY2023 figure was -$1.3 million, 417.24% down from the prior year.
  • Gross Profit for Q3 2025 was -$363000.0 at Envoy Medical, down from -$156000.0 in the prior quarter.
  • Across five years, Gross Profit topped out at $97000.0 in Q2 2023 and bottomed at -$1.0 million in Q4 2023.
  • The 4-year median for Gross Profit is -$143500.0 (2022), against an average of -$227833.3.
  • The largest annual shift saw Gross Profit plummeted 675.57% in 2023 before it skyrocketed 67.92% in 2024.
  • A 4-year view of Gross Profit shows it stood at -$131000.0 in 2022, then tumbled by 675.57% to -$1.0 million in 2023, then skyrocketed by 87.11% to -$131000.0 in 2024, then crashed by 177.1% to -$363000.0 in 2025.
  • Per Business Quant, the three most recent readings for COCH's Gross Profit are -$363000.0 (Q3 2025), -$156000.0 (Q2 2025), and -$312000.0 (Q1 2025).